A1XEH4 Crossject SA

Crossject trading on Euronext to resume as usual on Wednesday April 3

Crossject trading on Euronext to resume as usual on Wednesday April 3

Dijon, France April 2, 2024 – Trading of the stock of Crossject (ISIN: FR0011716265; Euronext: ALCJ) on the Euronext exchange will resume as normal on Wednesday, April 3 at 09:00 CET.

Crossject’s press release, entitled “Crossject advances in its U.S. Strategy and reports Financial Results for 2023”, was published at 10:30am CET, due to a delay in receiving certain confirmations.

For that reason, Crossject required Euronext to stop trading. Following Euronext’s standard procedure in such cases, trading will restart the following day.

About Crossject

Crossject SA (Euronext: ALCJ; ) is an emerging specialty pharma company. It is in advanced regulatory development for ZEPIZURE®, an epileptic rescue therapy, for which it has a $60 million contract with the U.S. Biomedical Advanced Research and Development Authority (BARDA). ZEPIZURE® is based on the Company’s award-winning needle-free autoinjector ZENEO®, designed to enable patients and untrained caregivers to easily and instantly deliver emergency medication via intramuscular injection on bare skin or even through clothing. The Company’s other products in development include rescue therapies for allergic shocks, adrenal insufficiencies, opioid overdose and asthma attacks.

For further information, please contact:

Investors

Natasha Drapeau

Cohesion Bureau

7





Media

Sophie Baumont

Cohesion Bureau

49

 



Attachment



EN
02/04/2024

Underlying

A1XEH4Crossject SA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Crossject SA

Jean Danjou ... (+3)
  • Jean Danjou
  • Oliver Metzger
  • Thomas Zlowodzki
NK IMERYS SA
A1XEH4 CROSSJECT SA
TFI TELEVISION FRANCAISE 1 SA
ISS ISS A/S
NRG NRJ GROUP SA
ALTA ALTAREA SCA
BOSS HUGO BOSS AG
G24 SCOUT24 AG
BAMNB KONINKLIJKE BAM GROEP NV
GLB GLANBIA PLC
SAVE SAVENCIA SA
FIE FIELMANN AG
VID VIDRALA SA
VLK VAN LANSCHOT KEMPEN NV CERT. OF SHS
AED AEDIFICA SA
BEZ BERENTZEN GRUPPE
WAF SILTRONIC AG
TWEKA TKH GROUP N.V. CERT
OREGE OREGE SA
LNSX SIXT LEASING AG
FFARM FORFARMERS
MVC METROVACESA SA
VOS VOSSLOH AG
NEOEN NEOEN S.A.
AML ASTON MARTIN LAGONDA GLOBAL HOLDINGS
TE TECHNIP ENERGIES NV
C3RY CHERRY AG
3h / 40m 3h / 40m 1 EN
Jean Danjou ... (+3)
  • Jean Danjou
  • Oliver Metzger
  • Thomas Zlowodzki
NK IMERYS SA
A1XEH4 CROSSJECT SA ... (+27)

ODDO BHF Small & MIDCAP MORNING NEWS - 02/05/2024

Nous sortons GALP de notre liste ODDO BHF European Large Caps. La valeur a réalisé une performance de +31,3% depuis son entrée le 20 mars dernier. Notre analyste adopte ce jour une opinion Neutre (vs Surperformance) sur la valeur qui a atteint notre objectif de cours. - ...

NK IMERYS SA
A1XEH4 CROSSJECT SA
TFI TELEVISION FRANCAISE 1 SA
ISS ISS A/S
NRG NRJ GROUP SA
ALTA ALTAREA SCA
BOSS HUGO BOSS AG
G24 SCOUT24 AG
BAMNB KONINKLIJKE BAM GROEP NV
GLB GLANBIA PLC
SAVE SAVENCIA SA
FIE FIELMANN AG
VID VIDRALA SA
VLK VAN LANSCHOT KEMPEN NV CERT. OF SHS
AED AEDIFICA SA
BEZ BERENTZEN GRUPPE
WAF SILTRONIC AG
TWEKA TKH GROUP N.V. CERT
OREGE OREGE SA
LNSX SIXT LEASING AG
FFARM FORFARMERS
MVC METROVACESA SA
VOS VOSSLOH AG
NEOEN NEOEN S.A.
AML ASTON MARTIN LAGONDA GLOBAL HOLDINGS
TE TECHNIP ENERGIES NV
C3RY CHERRY AG
4h / 52m 4h / 52m 1 FR
Martial Descoutures ... (+2)
  • Martial Descoutures
  • Oussema Denguir
A1XEH4 CROSSJECT SA

Crossject : Fund raising to prepare for hoped-for Zepizure approval in...

>Capital increase of € 8m with a discount of 10% - Crossject on Tuesday announced the launch of a capital increase for € 8m. This deal is secured through its long-standing shareholder Gemme Venture. The latter has committed to subscribing to at least € 1.96m worth (24.5% of the capital increase) and will guarantee a total amount of € 6m, or 75% of the fund raising.The subscription price is € 1.848 which equates to a discount of 10% to the last share price (4.3m n...

5h / 40m 5h / 40m 1 EN
Martial Descoutures ... (+2)
  • Martial Descoutures
  • Oussema Denguir
A1XEH4 CROSSJECT SA

Crossject : Une levée de fonds pour préparer l’approbation de Zepizure...

>Augmentation de capital de 8 M€ avec une décote de 10% - Crossject annonçait mardi soir le lancement d’une augmentation de capital pour un montant de 8 M€. Cette opération est sécurisée par l’intermédiaire de son actionnaire historique Gemme Venture. En effet, ces derniers s’engagent à souscrire à minima pour 1,96 M€ (24,5% de l’AK) et garantissent un montant total de 6 M€ c’est-à-dire 75% de la levée.Le prix de souscription est de 1,848 € ce qui correspond à un...

6h / 58m 6h / 58m 1 FR
Fabrice Farigoule
  • Fabrice Farigoule
A1XEH4 CROSSJECT SA

We welcome the securing of the group’s financial needs

We welcome the securing of the group’s financial needs FINANCING ISSUE We welcome the launch of a c. €8m capital increase aimed at securing the needs of the group until the Emergency Use Authorization is reached, in the Q125 according to the management. It will give the management some room for manoeuvre as well as calm investor fears in a context where the financing of the development of Zepizure was not clear after September 2024. FACT Crossject has announced a capital increase with prefe...

7h / 46m 7h / 46m 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch